Strategy

Europe's pharma uses deals to rationalise

Read more

Forbion looks for emerging science

Read more

How Britain champions medical innovation

Read more

How outcomes measures can improve healthcare

Read more

Commentary: Big deals for Big Pharma

Read more

Alkermes pioneers trial design in depression

Read more

What entrepreneurs should know about China

Read more

The stakes for biopharma from German drug policy

Read more

Johnson & Johnson brings partnering to the frontline

Read more

How BioCity Nottingham is rebuilding pharma

Read more